# US 2023/0058276 A1 · Methods for harvesting biomolecules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0058276 A1
- Document ID: US20230058276A1
- Status: Published application
- Kind: A1
- Application number: 17/794,889
- Filed: 2021-01-22
- Published: 2023-02-23
- Earliest claimed: 2020-01-24
- Assignees: Amgen Inc.
- Applicants: Amgen Inc.
- Inventors: Thomas Clark Pearson; Sarah Whetstone; Jeremy S. Conner
- Web page: https://patentgrep.com/patent/US20230058276A1

## CPC

- C07K 1/14: Extraction; Separation; Purification
- C07K 1/36: by a combination of two or more processes of different types
- C07K 1/34: by filtration, ultrafiltration or reverse osmosis
- C12M 33/10: {by centrifugation (centrifuges in general B04B); Cyclones (cyclones in general B04C)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

The disclosure provides methods of purifying native and recombinant biomolecules, e.g., proteins, from mammalian cells using purification protocols incorporating harvest recovery operations involving decanter centrifugation of at least one target biomolecule from at least one particulate component of cell culture fluid. The unexpected capacity of decanter centrifuge separation of biological materials of similar densities found in mammalian cell culture fluid has been found to yield high quantities of functional protein in efficient, low-cost harvest recovery steps of biomolecule purification protocols.

## Claims

### Claim 1

A method for separating protein produced in a mammalian cell from at least one other mammalian cell component comprising:
(a) introducing a fluid comprising mammalian cells into at least one decanter centrifuge;
(b) operating the decanter centrifuge, thereby separating fluid components into a low density composition and a high density composition;
(c) collecting the low density composition or recycling the low density composition through the decanter centrifuge; and
(d) recycling the high density composition through the decanter centrifuge or passing the high density composition to waste,
wherein the fluid components comprise mammalian cells and components of mammalian cells, further wherein the low density composition comprises the protein.

### Claim 2 (depends on 1)

The method of claim 1 wherein the fluid comprising mammalian cells is a culture harvest from a bioreactor comprising cultured mammalian cells.

### Claim 3 (depends on 2)

The method of claim 2 wherein a continuous stream of culture harvest is introduced into at least one decanter centrifuge.

### Claim 4 (depends on 2)

The method of claim 2 wherein a discontinuous batch of culture harvest is introduced into at least one decanter centrifuge.

### Claim 5 (depends on 1)

The method of claim 1 wherein the at least one decanter centrifuge is a plurality of decanter centrifuges.

### Claim 6 (depends on 5)

The method of claim 5 wherein the plurality of decanter centrifuges is two decanter centrifuges.

### Claim 7 (depends on 1)

The method of claim 1 wherein the high density composition is recycled through the decanter centrifuge.

### Claim 8 (depends on 1)

The method of claim 1 wherein the low density composition is recycled at least one time through a bioreactor comprising a culture of the mammalian cells.

### Claim 9 (depends on 1)

The method of claim 1 wherein the protein is a synthetic protein.

### Claim 10 (depends on 1)

The method of claim 1 wherein the protein is a recombinant protein.

### Claim 11 (depends on 10)

The method of claim 10 wherein the recombinant protein is a eukaryotic protein.

### Claim 12 (depends on 11)

The method of claim 11 wherein the eukaryotic protein is a mammalian protein.

### Claim 13 (depends on 12)

The method of claim 12 wherein the mammalian protein is an antibody chain or an antigen-binding fragment thereof.

### Claim 14 (depends on 12)

The method of claim 12 wherein the mammalian protein is an antigen-binding protein.

### Claim 15 (depends on 14)

The method of claim 14 wherein the antigen-binding protein is an antibody, a peptibody, an antibody fragment, an antibody derivative, an antibody analog, a fusion protein, a mutein, a bispecific protein or a multispecific protein.

### Claim 16 (depends on 15)

The method of claim 15 wherein the antibody is a whole antibody, a single-chain variable fragment, a Fv, a Fab, a Fab′, a F(ab′)2, a diabody, a triabody, a tetrabody, a BiTE, a Fd, a dAb, a minibody, or a maxibody.

### Claim 17 (depends on 1)

The method of claim 1 wherein the protein is a chimera.

### Claim 18 (depends on 17)

The method of claim 17 wherein the chimera comprises an antibody chain or an antigen-binding fragment thereof comprising light chain complementarity determining regions 1, 2 and 3 or heavy chain complementarity determining regions 1, 2 and 3.

### Claim 19 (depends on 17)

The method of claim 17 wherein the chimera is a Chimeric Antigen Receptor (CAR).

### Claim 20 (depends on 1)

The method of claim 1 wherein the protein is a granulocyte colony-stimulating factor, an erythropoiesis stimulating agent, a HER receptor, a cell adhesion molecule, a growth factor, an osteoinductive factor, insulin, a coagulation protein, a colony stimulating factor, a blood group antigen; a growth hormone, a growth hormone receptor, a T-cell receptor; a neurotrophic factor, a neurotrophin, a relaxin, an interferon, an interleukin, a viral antigen, a lipoprotein, an integrin, a rheumatoid factor, an immunotoxin, a surface-membrane protein, a transport protein, a homing receptor, an addressin, a regulatory protein, or an immunoadhesin.

### Claim 21 (depends on 20)

The method of claim 20 wherein the growth factor is a nerve growth factor, a fibroblast growth factor, a transforming growth factor, or an insulin-like growth factor.

### Claim 22 (depends on 1)

The method of claim 1 further comprising subjecting the low density composition to a second centrifugation step.

### Claim 23 (depends on 22)

The method of claim 22 wherein the second centrifuge is a disk-stack centrifuge.

### Claim 24 (depends on 1)

The method of claim 1 further comprising subjecting the low density composition to a filtration step.

### Claim 25 (depends on 24)

The method of claim 24 wherein the filtration step is depth filtration or tangential flow filtration.

### Claim 26 (depends on 1)

The method of claim 1 further comprising subjecting the cell culture or the low density composition to acoustic wave separation.

### Claim 27 (depends on 1)

The method of claim 1 further comprising subjecting the low density composition to a flocculation step or a precipitation step.

### Claim 28 (depends on 22)

The method of claim 22 further comprising subjecting the low density composition to any one or more of a second centrifugation step, a filtration step, an acoustic wave separation step, a flocculation step or a precipitation step.

### Claim 29

A method for purifying a protein from a mammalian cell culture comprising:
(a) introducing a cell culture fluid comprising mammalian cells into at least one decanter centrifuge;
(b) operating the decanter centrifuge, thereby separating fluid components into a low density fluid composition and a high density fluid composition;
(c) subjecting the low density fluid composition to depth filtration to yield a filtered low density fluid composition;
(d) contacting the filtered low density fluid composition with at least one chromatography medium; and
(e) collecting fluid containing the protein from the chromatography medium, thereby purifying the protein.

### Claim 30 (depends on 29)

The method of claim 29 further comprising subjecting the low density composition to any one or more of a second centrifugation step, a second filtration step, an acoustic wave separation step, a flocculation step or a precipitation step.

### Claim 31 (depends on 29)

The method of claim 29 wherein the protein is an antibody or an antigen-binding fragment thereof.

### Claim 32 (depends on 31)

The method of claim 31 wherein the antibody or antigen-binding fragment thereof is a single-chain variable fragment, a Fv, a Fab, a Fab′, a F(ab′)2, a diabody, a triabody, a tetrabody, a BiTE, a Fd, a dAb, a minibody, or a maxibody.

### Claim 33 (depends on 31)

The method of claim 31 wherein the antibody or antigen-binding fragment thereof is a monoclonal antibody or antigen-binding fragment thereof.

### Claim 34 (depends on 31)

The method of claim 31 wherein the antibody or antigen-binding fragment thereof is contained in a chimera.

### Claim 35 (depends on 34)

The method of claim 34 wherein the chimera is a Chimeric Antigen Receptor.
